j*****7
发帖数: 4348 | | B*****e
发帖数: 2413 | 2 Nice. I may buy this one after four months.
If you want to bet on rebounce, you can buy some.
【在 j*****7 的大作中提到】
: 其实FDA的质疑不能算很凶的。
| j*****7
发帖数: 4348 | | h*****8
发帖数: 4754 | 4 牛X，一转眼就7-8%
【在 j*****7 的大作中提到】
: 明天就停盘了.
| j*****7
发帖数: 4348 | | h*****8
发帖数: 4754 | 6 已经+12%， 按说你该跑了吧？
【在 j*****7 的大作中提到】
: Cao, 翻正了。 明天 50:50.
| w***y
发帖数: 2537 | | h*****8
发帖数: 4754 | 8 NND，我8下面看，下了个单，就忙去了。
没FILL，悲剧了，有木有！
【在 w***y 的大作中提到】
: 这个喊的神准啊
| E**O
发帖数: 1980 | 9 MAY 12, 2011, 6:04 P.M. ET
FDA Panel Narrowly Backs Proposed BioMimetic Bone Device
Article
Email
Printer
Friendly
Share:
facebook ↓ More
smaller Text larger
By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES
WASHINGTON (Dow Jones)--A Food and Drug Administration advisory panel
narrowly backed the use of a proposed bone-graft device developed by
BioMimetic Therapeutics Inc. (BMTI).
The device, called Augment, is a synthetic product designed to be used in
certain foot and ankle surgeries that fuse bones together, often to treat
joint pain. The product was reviewed Thursday by a panel of non-FDA medical
experts, and they voted 10-to-8 in the affirmative in response to the
question of whether the benefits of the product outweigh its risks.
The panel voted 12-to-6 in the affirmative to the question of whether there
was "reasonable assurance" the product was safe, and voted 10-to-8 in the
affirmative to another question about whether the product was effective.
Although the votes taken together amount to a recommendation by the panel
that the FDA should approve the device, the agency considers close votes a
split decision.
FDA staff gave the product a negative review and focused on concerns that a
synthetic protein used in the product might promote the growth of existing
cancers.
BioMimetic officials said there "was absolutely no data" to suggest Augment
promotes cancer and said the product was shown to be equally effective to
another procedure known as autograft, which uses a person's own bone tissue
in fusion surgeries.
-By Jennifer Corbett Dooren; Dow Jones Newswires, 202-862-9294; jennifer.
c*****[email protected]
-0 | J********e
发帖数: 341 | 10 这个参照MELA，估计最终会被据，反正FDA正式决定前看跌。
【在 j*****7 的大作中提到】
: 其实FDA的质疑不能算很凶的。
|
|
